VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10 - GlobeNewswire

Submitted by Anonymous (not verified) on Wed, 02/13/2019 - 08:00

VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10  GlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company ...